tyrosine and Anterior Horn Cell Disease

tyrosine has been researched along with Anterior Horn Cell Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccitto, M; Clardy, J; Driscoll, M; Georgiades, SN; Kalb, RG; Liu, Y; Mano, I; Merry, D; Mojsilovic-Petrovic, J; Nedelsky, N; Neve, RL; Taylor, JP; Zhou, W1
Banerjee, P; Berry-Kravis, E; Boyers, MJ; Dawson, G1
Beal, MF; Ferrante, RJ; Gurney, ME; Kowall, NW; Matthews, RT; Schulz, JB; Shinobu, LA; Thomas, CE1
Duncan, MW; Gurney, ME; Pamphlett, R; Poljak, A1
Halliwell, B; Hyun, DH; Jenner, P; Lee, M1

Other Studies

5 other study(ies) available for tyrosine and Anterior Horn Cell Disease

ArticleYear
FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jun-24, Volume: 29, Issue:25

    Topics: Animals; Blotting, Western; Cell Count; Cell Culture Techniques; Cell Death; Computational Biology; Disease Models, Animal; Drosophila; Embryo, Mammalian; Excitatory Amino Acid Agonists; Female; Fluorescence; Forkhead Box Protein O3; Forkhead Transcription Factors; Immunohistochemistry; Kainic Acid; Mice; Mice, Inbred C57BL; Motor Neuron Disease; Motor Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord; Tyrosine

2009
Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient.
    The Journal of biological chemistry, 1994, Feb-18, Volume: 269, Issue:7

    Topics: Adult; Alleles; Amino Acid Sequence; Animals; beta-N-Acetylhexosaminidases; Cell Line; Exons; Female; Genetic Carrier Screening; Hexosaminidase A; Hexosaminidase B; Humans; Macromolecular Substances; Male; Motor Neuron Disease; Point Mutation; Protein Structure, Secondary; Sandhoff Disease; Serine; Transfection; Tyrosine

1994
Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.
    Annals of neurology, 1997, Volume: 42, Issue:3

    Topics: Analysis of Variance; Animals; Cerebral Cortex; Copper; Heme Oxygenase (Decyclizing); Humans; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Mutant Strains; Mice, Transgenic; Motor Neuron Disease; Point Mutation; Protein Binding; Spinal Cord; Superoxide Dismutase; Tyrosine; Zinc

1997
Measurement of o- and m-tyrosine as markers of oxidative damage in motor neuron disease.
    Redox report : communications in free radical research, 2000, Volume: 5, Issue:2-3

    Topics: Animals; Biomarkers; Brain Chemistry; Humans; Isomerism; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Neuron Disease; Muscle, Skeletal; Spinal Cord; Superoxide Dismutase; Tyrosine

2000
Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and pro
    Journal of neurochemistry, 2001, Volume: 78, Issue:2

    Topics: Aldehydes; Amino Acid Substitution; Cell Death; Cell Survival; Cross-Linking Reagents; Culture Media, Serum-Free; Genes, bcl-2; Guanine; Humans; Hydrogen Peroxide; Kinetics; Lipid Peroxidation; Motor Neuron Disease; Mutagenesis, Site-Directed; Neuroblastoma; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Superoxide Dismutase; Superoxide Dismutase-1; Teratocarcinoma; Tumor Cells, Cultured; Tyrosine

2001